Delayed breast cancer relapse with pleural metastasis and malignant pleural effusion after long periods of disease-free survival

被引:8
|
作者
Rawindraraj, Antony Divananth [1 ]
Zhou, Christine Yang [1 ]
Pathak, Vikas [1 ,2 ]
机构
[1] Campbell Univ, Sch Osteopath Med, Dept Internal Med, Lillington, NC USA
[2] WakeMed Hlth & Hosp, Dept Pulm & Crit Care Med, Raleigh, NC USA
来源
RESPIROLOGY CASE REPORTS | 2018年 / 6卷 / 09期
关键词
Breast cancer relapse; breast cancer metastasis; malignant pleural effusion; pleural effusion;
D O I
10.1002/rcr2.375
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Breast cancer relapse remains a common cause of morbidity and mortality in patients who undergo initial treatment with surgery and with or without concurrent chemotherapy or radiation. Relapse rates remain high within the first decade after initial treatment, after which the risk of relapse decreases. While common within the first year of breast cancer diagnosis, pleural metastasis with malignant pleural effusion (MPE) after 10-12 years of a disease-free period is rare. Here, we present two uncommon cases of delayed breast cancer relapses with pleural metastasis, which caused MPEs.
引用
收藏
页数:3
相关论文
共 40 条
  • [21] Intrapleural paclitaxel for malignant pleural effusion from ovarian and breast cancer: a phase II study with pharmacokinetic analysis
    Lombardi, Giuseppe
    Nicoletto, Maria Ornella
    Gusella, Milena
    Fiduccia, Pasquale
    Dalla Palma, Maurizia
    Zuin, Andrea
    Fiore, Davide
    Donach, Martin
    Zagonel, Vittorina
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 69 (03) : 781 - 787
  • [22] Survival Benefits for Pulmonary Adenocarcinoma With Malignant Pleural Effusion After Thoracoscopic Surgical Treatment: A Real-World Study
    Li, Xin
    Li, Mingbiao
    Lv, Jinshuang
    Liu, Jinghao
    Dong, Ming
    Xia, Chunqiu
    Zhao, Honglin
    Xu, Song
    Wei, Sen
    Song, Zuoqing
    Chen, Gang
    Liu, Hongyu
    Chen, Jun
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [23] Demonstration of anti-tumor activity of oncolytic measles virus strains in a malignant pleural effusion breast cancer model
    Iankov, Ianko D.
    Msaouel, Pavlos
    Allen, Cory
    Federspiel, Mark J.
    Bulur, Peggy A.
    Dietz, Allan B.
    Gastineau, Dennis
    Ikeda, Yasuhiro
    Ingle, James N.
    Russell, Stephen J.
    Galanis, Evanthia
    BREAST CANCER RESEARCH AND TREATMENT, 2010, 122 (03) : 745 - 754
  • [24] Demonstration of anti-tumor activity of oncolytic measles virus strains in a malignant pleural effusion breast cancer model
    Ianko D. Iankov
    Pavlos Msaouel
    Cory Allen
    Mark J. Federspiel
    Peggy A. Bulur
    Allan B. Dietz
    Dennis Gastineau
    Yasuhiro Ikeda
    James N. Ingle
    Stephen J. Russell
    Evanthia Galanis
    Breast Cancer Research and Treatment, 2010, 122 : 745 - 754
  • [25] Vascular Endothelial Growth Factor in Plasma and Pleural Effusion Is a Biomarker for Outcome After Bevacizumab plus Carboplatin-Paclitaxel Treatment for Non-small Cell Lung Cancer with Malignant Pleural Effusion
    Tamiya, Motohiro
    Tamiya, Akihiro
    Yasue, Tomomi
    Nakao, Keiko
    Omachi, Naoki
    Shiroyama, Takayuki
    Tani, Eriko
    Hamaguchi, Masanari
    Morishita, Naoko
    Suzuki, Hidekazu
    Okamoto, Norio
    Okishio, Kyoichi
    Kawaguchi, Tomoya
    Atagi, Shinji
    Hirashima, Tomonori
    ANTICANCER RESEARCH, 2016, 36 (06) : 2939 - 2944
  • [26] Effects of bevacizumab combined with oxaliplatin intrathoracic injection on tumor markers and survival rate in patients with malignant pleural effusion of lung cancer
    Chen, Xiaoju
    Lu, Jiali
    Yao, Yien
    Huang, Zhongchen
    Liu, Ke
    Jiang, Wenxin
    Li, Chaoqian
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2021, 13 (04): : 2899 - 2906
  • [27] A Novel Clinical Prognostic Model for Breast Cancer Patients with Malignant Pleural Effusion: Avoiding Chemotherapy in Low-Risk Groups?
    Wang, Yichen
    Zhou, Tao
    Zhao, Shanshan
    Li, Ning
    Sun, Siwen
    Li, Man
    CANCER MANAGEMENT AND RESEARCH, 2023, 15 : 409 - 422
  • [28] Hyperthermic intrathoracic chemotherapy for the treatment of malignant pleural effusion caused by breast and ovarian cancer: A systematic literature review and pooled analysis
    Karampinis, Ioannis
    Dionysopoulou, Anna
    Galata, Christian
    Almstedt, Katrin
    Grilli, Maurizio
    Hasenburg, Annette
    Roessner, Eric D.
    THORACIC CANCER, 2022, 13 (07) : 883 - 888
  • [29] Combination of long noncoding RNA MALAT1 and carcinoembryonic antigen for the diagnosis of malignant pleural effusion caused by lung cancer
    Wang, Wan-Wei
    Zhou, Xi-Lei
    Song, Ying-Jian
    Yu, Chang-Hua
    Zhu, Wei-Guo
    Tong, Yu-Suo
    ONCOTARGETS AND THERAPY, 2018, 11 : 2333 - 2344
  • [30] Machine Learning Assisted Real-Time Label-Free SERS Diagnoses of Malignant Pleural Effusion due to Lung Cancer
    Perumal, Jayakumar
    Lee, Pyng
    Dev, Kapil
    Lim, Hann Qian
    Dinish, U. S.
    Olivo, Malini
    BIOSENSORS-BASEL, 2022, 12 (11):